<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>) comprises three related yet biologically distinct subtypes--splenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>), nodal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (NMZL), and extranodal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> of MALT type (MALT) </plain></SENT>
<SENT sid="1" pm="."><plain>In cases without adequate <z:mp ids='MP_0000002'>morphology</z:mp>, immunophenotypic characterization by flow cytometric immunophenotyping (FCI) relies heavily on exclusion of other low-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We performed a retrospective review of FCI studies of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> to search for immunophenotypes specific for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> and its subtypes </plain></SENT>
<SENT sid="3" pm="."><plain>We compared these to follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) as we were specifically interested in differentiating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> from CD10 negative FL </plain></SENT>
<SENT sid="4" pm="."><plain>DESIGN: FCI findings for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> and FL cases were reviewed </plain></SENT>
<SENT sid="5" pm="."><plain>Statistical analysis of patterns and intensity of antigen expression [mean channel fluorescence (MCF)] were performed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Thirty-one cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (7 SMZL, 6 NMZL, 15 MALT, 3 MZL not otherwise specified) and 31 cases of FL were identified </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> expressed CD19, CD20, and CD45 </plain></SENT>
<SENT sid="8" pm="."><plain>Thirty-two percent of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> and 77% of FL expressed CD38 </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of CD11c was seen in 57% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> and 8% of other <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (P &lt; 0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>Statistically significant differences in antigen expression between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> and FL were seen for CD10, CD11c, and CD38 </plain></SENT>
<SENT sid="11" pm="."><plain>CD19 expression was significantly brighter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (mean MCF of 455.3) than in FL (mean MCF of 166.9) (P &lt; 0.001) </plain></SENT>
<SENT sid="12" pm="."><plain>MCF for isotype controls and CD20 were similar for FL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> expresses typical pan-B-cell antigens </plain></SENT>
<SENT sid="14" pm="."><plain>Expression of CD11c is highly associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Levels of CD19 expression in conjunction with CD11c and CD38 expression can distinguish <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> from CD10 negative FL </plain></SENT>
</text></document>